Latest News and Press Releases
Want to stay updated on the latest news?
-
MOUNTAIN VIEW, Calif., Nov. 12, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
-
MOUNTAIN VIEW, Calif., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST) today announced that its stockholders have approved the previously announced acquisition of Pharsight by...
-
MOUNTAIN VIEW, Calif., Oct. 21, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
-
MOUNTAIN VIEW, Calif., and LONDON, Oct. 7, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing...
-
Pharsight to Present On Modeling and Simulation At 'Magic Bullets' to Treat Disease World Conference
MOUNTAIN VIEW, Calif., Sept. 30, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical...
-
MOUNTAIN VIEW, Calif., Sept. 15, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical...
-
MOUNTAIN VIEW, Calif., Sept. 11, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical...
-
ST. LOUIS and MOUNTAIN VIEW, Calif., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Tripos, a leading provider of drug discovery informatics products and services, and Pharsight Corporation (Nasdaq:PHST), a...
-
MOUNTAIN VIEW, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
-
MOUNTAIN VIEW, Calif., July 31, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...